[Detection of DPD-exon-14 skipping before 5-fluorouracil treatment?].
Kliche
Kay-Oliver
KO
D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects* / Q000378:metabolism / Q000627:therapeutic use*; D015415:Biomarkers; D042943:Dihydrouracil Dehydrogenase (NADP); D005091:Exons; D005472:Fluorouracil / Q000009:adverse effects* / Q000378:metabolism / Q000627:therapeutic use*; D006579:Heterozygote; D006720:Homozygote; D006801:Humans; D007438:Introns / Q000235:genetics; D009154:Mutation; D010088:Oxidoreductases / Q000235:genetics*; D010597:Pharmacogenetics; D017354:Point Mutation; D012189:Retrospective Studies; D013997:Time Factors
D000964:Antimetabolites, Antineoplastic; D015415:Biomarkers; D010088:Oxidoreductases; D042943:Dihydrouracil Dehydrogenase (NADP); D005472:Fluorouracil